High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay

Michael P. Crawford, Shirley X. Yan, Sterling B. Ortega, Riyaz S. Mehta, Rachel E. Hewitt, David A. Price, Peter Stastny, Daniel C. Douek, Richard A. Koup, Michael K. Racke, Nitin J. Karandikar

Research output: Contribution to journalArticle

181 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS) with features suggestive of T-cell-mediated pathology. Most prior reports have focused on CD4+ T cells with the underlying assumption that MS is predominantly a CD4+ T helper 1 (Th1)-mediated disease. In this report, we used a novel flow cytometric approach to evaluate autoreactive T-cell responses against a large variety of neuroantigenic targets. We found that both CD4+ and CD8+ T cells targeted against several CNS autoantigens were widely prevalent in patients with MS and healthy individuals. Whereas the distribution of CD4 + responses was similar in different groups, patients with relapsing-remitting MS showed a higher proportion of CNS-specific CD8 + responses. Autoreactive CD4+ T cells from patients with MS exhibited a more differentiated Th1 phenotype compared with healthy subjects. Similarly, CNS-specific CD8+ T-cell responses from patients with MS were functionally distinct from those in healthy individuals. Collectively, these studies reveal the high prevalence of class I-restricted autoreactive CD8+ T-cell responses in MS that has been underappreciated thus far. The results emphasize the need to evaluate both CD4+ and CD8 + T-cell responses in MS and to make both subsets a consideration in the development of novel therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)4222-4231
Number of pages10
JournalBlood
Volume103
Issue number11
DOIs
StatePublished - Jun 1 2004

Fingerprint

T-cells
Multiple Sclerosis
Assays
T-Lymphocytes
Neurology
Central Nervous System
Relapsing-Remitting Multiple Sclerosis
Autoantigens
Demyelinating Diseases
Pathology
Healthy Volunteers
Phenotype

ASJC Scopus subject areas

  • Hematology

Cite this

Crawford, M. P., Yan, S. X., Ortega, S. B., Mehta, R. S., Hewitt, R. E., Price, D. A., ... Karandikar, N. J. (2004). High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood, 103(11), 4222-4231. https://doi.org/10.1182/blood-2003-11-4025

High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. / Crawford, Michael P.; Yan, Shirley X.; Ortega, Sterling B.; Mehta, Riyaz S.; Hewitt, Rachel E.; Price, David A.; Stastny, Peter; Douek, Daniel C.; Koup, Richard A.; Racke, Michael K.; Karandikar, Nitin J.

In: Blood, Vol. 103, No. 11, 01.06.2004, p. 4222-4231.

Research output: Contribution to journalArticle

Crawford, MP, Yan, SX, Ortega, SB, Mehta, RS, Hewitt, RE, Price, DA, Stastny, P, Douek, DC, Koup, RA, Racke, MK & Karandikar, NJ 2004, 'High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay', Blood, vol. 103, no. 11, pp. 4222-4231. https://doi.org/10.1182/blood-2003-11-4025
Crawford, Michael P. ; Yan, Shirley X. ; Ortega, Sterling B. ; Mehta, Riyaz S. ; Hewitt, Rachel E. ; Price, David A. ; Stastny, Peter ; Douek, Daniel C. ; Koup, Richard A. ; Racke, Michael K. ; Karandikar, Nitin J. / High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. In: Blood. 2004 ; Vol. 103, No. 11. pp. 4222-4231.
@article{9e87156836804226a46b1ffea2c4e75b,
title = "High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay",
abstract = "Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS) with features suggestive of T-cell-mediated pathology. Most prior reports have focused on CD4+ T cells with the underlying assumption that MS is predominantly a CD4+ T helper 1 (Th1)-mediated disease. In this report, we used a novel flow cytometric approach to evaluate autoreactive T-cell responses against a large variety of neuroantigenic targets. We found that both CD4+ and CD8+ T cells targeted against several CNS autoantigens were widely prevalent in patients with MS and healthy individuals. Whereas the distribution of CD4 + responses was similar in different groups, patients with relapsing-remitting MS showed a higher proportion of CNS-specific CD8 + responses. Autoreactive CD4+ T cells from patients with MS exhibited a more differentiated Th1 phenotype compared with healthy subjects. Similarly, CNS-specific CD8+ T-cell responses from patients with MS were functionally distinct from those in healthy individuals. Collectively, these studies reveal the high prevalence of class I-restricted autoreactive CD8+ T-cell responses in MS that has been underappreciated thus far. The results emphasize the need to evaluate both CD4+ and CD8 + T-cell responses in MS and to make both subsets a consideration in the development of novel therapeutic strategies.",
author = "Crawford, {Michael P.} and Yan, {Shirley X.} and Ortega, {Sterling B.} and Mehta, {Riyaz S.} and Hewitt, {Rachel E.} and Price, {David A.} and Peter Stastny and Douek, {Daniel C.} and Koup, {Richard A.} and Racke, {Michael K.} and Karandikar, {Nitin J.}",
year = "2004",
month = "6",
day = "1",
doi = "10.1182/blood-2003-11-4025",
language = "English (US)",
volume = "103",
pages = "4222--4231",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "11",

}

TY - JOUR

T1 - High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay

AU - Crawford, Michael P.

AU - Yan, Shirley X.

AU - Ortega, Sterling B.

AU - Mehta, Riyaz S.

AU - Hewitt, Rachel E.

AU - Price, David A.

AU - Stastny, Peter

AU - Douek, Daniel C.

AU - Koup, Richard A.

AU - Racke, Michael K.

AU - Karandikar, Nitin J.

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS) with features suggestive of T-cell-mediated pathology. Most prior reports have focused on CD4+ T cells with the underlying assumption that MS is predominantly a CD4+ T helper 1 (Th1)-mediated disease. In this report, we used a novel flow cytometric approach to evaluate autoreactive T-cell responses against a large variety of neuroantigenic targets. We found that both CD4+ and CD8+ T cells targeted against several CNS autoantigens were widely prevalent in patients with MS and healthy individuals. Whereas the distribution of CD4 + responses was similar in different groups, patients with relapsing-remitting MS showed a higher proportion of CNS-specific CD8 + responses. Autoreactive CD4+ T cells from patients with MS exhibited a more differentiated Th1 phenotype compared with healthy subjects. Similarly, CNS-specific CD8+ T-cell responses from patients with MS were functionally distinct from those in healthy individuals. Collectively, these studies reveal the high prevalence of class I-restricted autoreactive CD8+ T-cell responses in MS that has been underappreciated thus far. The results emphasize the need to evaluate both CD4+ and CD8 + T-cell responses in MS and to make both subsets a consideration in the development of novel therapeutic strategies.

AB - Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS) with features suggestive of T-cell-mediated pathology. Most prior reports have focused on CD4+ T cells with the underlying assumption that MS is predominantly a CD4+ T helper 1 (Th1)-mediated disease. In this report, we used a novel flow cytometric approach to evaluate autoreactive T-cell responses against a large variety of neuroantigenic targets. We found that both CD4+ and CD8+ T cells targeted against several CNS autoantigens were widely prevalent in patients with MS and healthy individuals. Whereas the distribution of CD4 + responses was similar in different groups, patients with relapsing-remitting MS showed a higher proportion of CNS-specific CD8 + responses. Autoreactive CD4+ T cells from patients with MS exhibited a more differentiated Th1 phenotype compared with healthy subjects. Similarly, CNS-specific CD8+ T-cell responses from patients with MS were functionally distinct from those in healthy individuals. Collectively, these studies reveal the high prevalence of class I-restricted autoreactive CD8+ T-cell responses in MS that has been underappreciated thus far. The results emphasize the need to evaluate both CD4+ and CD8 + T-cell responses in MS and to make both subsets a consideration in the development of novel therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=2542418993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542418993&partnerID=8YFLogxK

U2 - 10.1182/blood-2003-11-4025

DO - 10.1182/blood-2003-11-4025

M3 - Article

C2 - 14976054

AN - SCOPUS:2542418993

VL - 103

SP - 4222

EP - 4231

JO - Blood

JF - Blood

SN - 0006-4971

IS - 11

ER -